DeDora Capital’s Humana HUM Stock Holding History

DeDora Capital’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-111	Closed	-$48K	–	230
2022 Q1	$48K	Buy	+111	New	+$46.4K	0.02%	165

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DeDora Capital's HUM Position: Q2 2022 in Review

DeDora Capital sold out of Humana (HUM) in Q2 2022, closing a stake of 111 shares — an estimated $48K sold.

DeDora Capital first reported a position in HUM in Q1 2022 and held it in 1 quarter. The position peaked at $48K in Q1 2022. 959 funds tracked by Wall St. Rank hold HUM as of Q2 2022.

DeDora Capital reported no remaining Humana position as of Q2 2022 after selling out during the quarter.
DeDora Capital sold 111 Humana shares in Q2 2022, an estimated $48K.
DeDora Capital first reported a position in Humana in Q1 2022 and held it in 1 quarter.
DeDora Capital's Humana position peaked at $48K in Q1 2022.
959 funds tracked by Wall St. Rank held Humana as of Q2 2022.

Based on DeDora Capital's 13F filing for Q2 2022, filed 27 Jul 2022.